Why the study?
What is the dose-response relationship of various ACE inhibitors for blood pressure reduction and plasma ACE inhibition?
What is the dose-response relationship of various ACE inhibitors for blood pressure reduction and plasma ACE inhibition?
Current recommended starting doses for some ACE inhibitors may be excessive, highlighting the need for careful dose titration in at-risk patients.
Answers are grounded in this paper and cite their sources.
May support lower starting doses for benazepril and captopril; leaves open confirmation in prospective dose-response trials.
Current usage: Plasma angiotensin converting enzyme (ACE) inhibition and doseresponse relationships during blood pressure reductions were compared for several marketed ACE inhibitor compounds. Both peak and trough responses are considered and contrasted. The presently recommended antihypertensive doses of enalapril, lisinopril, perindopril and ramipril appear to lie within the linear range of the antihypertensive dose-response relationship. For benazepril and captopril, the recommended doses may be in the flat, upper part of the relationship. Recommendations: The recommended doses for initiating antihypertensive therapy may still be excessive in patients at risk of heightened pharmacodynamic responses. Further studies are required to clarify the dose-response relationship for all of these compounds.
No takes yet. Share an insight, caveat, or question.
Kennedy R. Lees (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: